Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 2/2012

01.02.2012 | Maternal-Fetal Medicine

Peripartum use of cell salvage: a university practice audit and literature review

verfasst von: Aharon Tevet, Sorina Grisaru-Granovsky, Arnon Samueloff, Alexander Ioscovich

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Obstetrical hemorrhage is the second leading cause of direct maternal mortality (18% of maternal deaths) in developed countries and is the leading cause of severe maternal morbidity. The rising rate of obstetrical hemorrhage attributed to the repeated cesarean sections and invasive placental disorders, requiring blood transfusion has emphasized the need for alternatives to allogeneic blood donation.

Methods and results

The Shaare Zedek Medical Center is a teaching hospital with the largest obstetric service in the region—13,500 live births per year. The medical records of all parturients requiring use of intraoperative cell salvage system (IOCS) (2007–2011) were reviewed to evaluate our experience with this unique system and possible complications in the obstetrical milieu of a large obstetric unit.

Conclusion

Using our combined medical records, we found that IOCS is a rapid method of blood replacement that allows blood bank service recruitment and presents no adverse reaction to the parturient. However, this sophisticated system is appropriate for tertiary surgical centers and its routine use should be assessed by national medical boards.
Literatur
1.
Zurück zum Zitat Hoyert DL (2007) Maternal mortality and related concepts. Vital Health Stat 3(33):1–13 Hoyert DL (2007) Maternal mortality and related concepts. Vital Health Stat 3(33):1–13
2.
Zurück zum Zitat Callaghan WM, Mackay AP et al (2008) Identification of severe maternal morbidity during delivery hospitalizations, United States, 1991–2003. Am J Obstet Gynecol 199(2): 133 e131–e138 Callaghan WM, Mackay AP et al (2008) Identification of severe maternal morbidity during delivery hospitalizations, United States, 1991–2003. Am J Obstet Gynecol 199(2): 133 e131–e138
3.
Zurück zum Zitat Knight M, Kurinczuk JJ et al (2005) The UK Obstetric Surveillance System for rare disorders of pregnancy. BJOG 112(3):263–265PubMedCrossRef Knight M, Kurinczuk JJ et al (2005) The UK Obstetric Surveillance System for rare disorders of pregnancy. BJOG 112(3):263–265PubMedCrossRef
4.
Zurück zum Zitat Wen SW, Huang L et al (2005) Severe maternal morbidity in Canada, 1991–2001. CMAJ 173(7):759–764PubMedCrossRef Wen SW, Huang L et al (2005) Severe maternal morbidity in Canada, 1991–2001. CMAJ 173(7):759–764PubMedCrossRef
5.
Zurück zum Zitat Zwart JJ, Richters JM et al (2008) Severe maternal morbidity during pregnancy, delivery and puerperium in the Netherlands: a nationwide population-based study of 371,000 pregnancies. BJOG 115(7):842–850PubMedCrossRef Zwart JJ, Richters JM et al (2008) Severe maternal morbidity during pregnancy, delivery and puerperium in the Netherlands: a nationwide population-based study of 371,000 pregnancies. BJOG 115(7):842–850PubMedCrossRef
6.
7.
Zurück zum Zitat Chief Medical Officer. Health Service Circular. Better Blood Transfusion. Appropriate use of Blood. Department of Health, Israel July 2002 Chief Medical Officer. Health Service Circular. Better Blood Transfusion. Appropriate use of Blood. Department of Health, Israel July 2002
8.
Zurück zum Zitat Tawes RL Jr (1994) Clinical applications of autotransfusion. Semin Vasc Surg 7(2):89–90PubMed Tawes RL Jr (1994) Clinical applications of autotransfusion. Semin Vasc Surg 7(2):89–90PubMed
9.
Zurück zum Zitat Tawes RL Jr, DuVall TB (1994) The basic concepts of an autotransfusor: the cell-saver. Semin Vasc Surg 7(2):93–94PubMed Tawes RL Jr, DuVall TB (1994) The basic concepts of an autotransfusor: the cell-saver. Semin Vasc Surg 7(2):93–94PubMed
10.
Zurück zum Zitat Orr M (1978) Autotransfusion: the use of washed red cells as an adjunct to component therapy. Surgery 84(5):728–732PubMed Orr M (1978) Autotransfusion: the use of washed red cells as an adjunct to component therapy. Surgery 84(5):728–732PubMed
11.
Zurück zum Zitat Berard F, Gandon J (1964) Postoperative wound infections: the influence of ultraviolet irradiation of the operating room and of various other factors. Ann Surg 160(Suppl 2):1–192PubMed Berard F, Gandon J (1964) Postoperative wound infections: the influence of ultraviolet irradiation of the operating room and of various other factors. Ann Surg 160(Suppl 2):1–192PubMed
12.
Zurück zum Zitat Waters JH, Potter PS (2000) Cell salvage in the Jehovah’s Witness patient. Anesth Analg 90(1):229–230PubMedCrossRef Waters JH, Potter PS (2000) Cell salvage in the Jehovah’s Witness patient. Anesth Analg 90(1):229–230PubMedCrossRef
13.
Zurück zum Zitat Potter PS, Waters JH et al (1999) Application of cell-salvage during cesarean section. Anesthesiology 90(2):619–621PubMedCrossRef Potter PS, Waters JH et al (1999) Application of cell-salvage during cesarean section. Anesthesiology 90(2):619–621PubMedCrossRef
14.
Zurück zum Zitat Steiner PE, Lushbaugh CC (1986) Landmark article, Oct. 1941: maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics. JAMA 255(16):2187–2203PubMedCrossRef Steiner PE, Lushbaugh CC (1986) Landmark article, Oct. 1941: maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics. JAMA 255(16):2187–2203PubMedCrossRef
15.
Zurück zum Zitat Zichella L, Gramolini R (1990) Autotransfusion during cesarean section. Am J Obstet Gynecol 162(1):295PubMed Zichella L, Gramolini R (1990) Autotransfusion during cesarean section. Am J Obstet Gynecol 162(1):295PubMed
16.
Zurück zum Zitat Fong J, Gurewitsch ED et al (1999) Clearance of fetal products and subsequent immunoreactivity of blood salvaged at cesarean delivery. Obstet Gynecol 93(6):968–972PubMedCrossRef Fong J, Gurewitsch ED et al (1999) Clearance of fetal products and subsequent immunoreactivity of blood salvaged at cesarean delivery. Obstet Gynecol 93(6):968–972PubMedCrossRef
17.
Zurück zum Zitat Lockwood CJ, Bach R et al (1991) Amniotic fluid contains tissue factor, a potent initiator of coagulation. Am J Obstet Gynecol 165(5 Pt 1):1335–1341PubMed Lockwood CJ, Bach R et al (1991) Amniotic fluid contains tissue factor, a potent initiator of coagulation. Am J Obstet Gynecol 165(5 Pt 1):1335–1341PubMed
18.
Zurück zum Zitat Booke M, Fobker M et al (1997) Fat elimination during intraoperative autotransfusion: an in vitro investigation. Anesth Analg 85(5):959–962PubMed Booke M, Fobker M et al (1997) Fat elimination during intraoperative autotransfusion: an in vitro investigation. Anesth Analg 85(5):959–962PubMed
19.
Zurück zum Zitat Lee W, Ginsburg KA et al (1986) Squamous and trophoblastic cells in the maternal pulmonary circulation identified by invasive hemodynamic monitoring during the peripartum period. Am J Obstet Gynecol 155(5):999–1001PubMed Lee W, Ginsburg KA et al (1986) Squamous and trophoblastic cells in the maternal pulmonary circulation identified by invasive hemodynamic monitoring during the peripartum period. Am J Obstet Gynecol 155(5):999–1001PubMed
20.
Zurück zum Zitat Adamsons K, Mueller-Heubach E et al (1971) The innocuousness of amniotic fluid infusion in the pregnant rhesus monkey. Am J Obstet Gynecol 109(7):977–984PubMed Adamsons K, Mueller-Heubach E et al (1971) The innocuousness of amniotic fluid infusion in the pregnant rhesus monkey. Am J Obstet Gynecol 109(7):977–984PubMed
21.
Zurück zum Zitat Benson MD, Kobayashi H et al (2001) Immunologic studies in presumed amniotic fluid embolism. Obstet Gynecol 97(4):510–514PubMedCrossRef Benson MD, Kobayashi H et al (2001) Immunologic studies in presumed amniotic fluid embolism. Obstet Gynecol 97(4):510–514PubMedCrossRef
22.
Zurück zum Zitat Ioscovich A, Mirochnitchenko E et al (2009) Perioperative anaesthetic management of high-order repeat caesarean section: audit of practice in a university-affiliated medical center. Int J Obstet Anesth 18(4):314–319PubMedCrossRef Ioscovich A, Mirochnitchenko E et al (2009) Perioperative anaesthetic management of high-order repeat caesarean section: audit of practice in a university-affiliated medical center. Int J Obstet Anesth 18(4):314–319PubMedCrossRef
Metadaten
Titel
Peripartum use of cell salvage: a university practice audit and literature review
verfasst von
Aharon Tevet
Sorina Grisaru-Granovsky
Arnon Samueloff
Alexander Ioscovich
Publikationsdatum
01.02.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2012
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-011-2164-7

Weitere Artikel der Ausgabe 2/2012

Archives of Gynecology and Obstetrics 2/2012 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.